By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Metabolomics firm Metabolon today announced it has completed a Series D financing round that raised $13.1 million.

New investor Keating Capital participated in the round, which also included existing investors Sevin Rosen Funds, Aurora Funds, Harris & Harris Group; Syngenta Ventures, Fletcher Spaght, and Fulcrum Financial Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.